Detail of the clinical trial

Title of the trial M14-675, A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis
EudraCT number 2016-000642-62
Protocol number M14-675
Sponsor AbbVie Deutschland GmbH & Co. KG, Knollstrasse 70, 67061 Ludwigshafen, Germany
Indications Internal medicine
Diagnosis Ulcerative Colitis
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2018
Date of approval by Institute (SÚKL) 14.11.2018
Date of approval by EC 14.1.2019
Date of initiation CT in ČR
Date of ending CT in ČR
Notice
Sites ISCARE I.V.F. a.s,Klinické a výzkumné centrum pro střevní záněty,Jankovcova 1569/2c,Praha,170 04
Artroscan s.r.o., Třebovická 5114/106, Ostrava -Třebovice,722 00
Axon Clinical, s.r.o., Ostrovského 253/3, Praha,150 00
CTCenter Mave s.r.o., Na Šibeníku 914/1, Olomouc,779 00
Hepato-Gastroenterologie HK, s.r.o.,Třída Edvarda Beneše 34/1549,Hradec Králové,500 12

‹‹ Back to list